introduction to ifpma and their role in global health policy · 2019-05-03 · introduction to...

Introduction to IFPMA | Committed to a healthier future

INTRODUCTION TO IFPMA AND THEIR

ROLE IN GLOBAL HEALTH POLICY

Dr. Mümün Gencoglu

Regulatory Affairs Manager - International Federation of

Pharmaceutical Manufacturers & Associations (IFPMA)


IFPMA is the voice for

biopharmaceutical innovation and

health progress around the world

VISION

To promote policies, dialogues

and initiatives that encourage

the discovery of and access to

medicines and vaccines globally

MISSION

THOUGHT LEADER

Share expertise in key fora about innovation, regulatory

and health policy issues

MISSION AND VISION

IFPMA in Brief

WHO WE ARE

SOLUTIONS PARTNER

Tackle health challenges responsibly and

collaboratively, to improve health outcomes

CONVENER

Build bridges within and across sectors to advance

mutual goals and gain trust


IFPMA is a strong, assertive voice for

the industry’s value proposition, with

a portfolio of constructive initiatives,

positioning the industry as thought

leaders and solutions partners.

IFPMA brings insights on

political and policy trends,

and external stakeholder

perspectives to its members.

Bridge between the industry and global health

stakeholders


Interlocutor for intergovernmental organizations

Consultative status with the United Nations:

Engage with other multilateral organizations:


IFPMA Membership

Americas: 11 Associations

Europe: 21 Associations

Middle East & Africa: 3 Associations

Asia Pacific: 15 Associations

Associations In

All 5 Continents

50

IFPMA is the industry interlocutor globally with ~50 associations and ~40 companies in

all 5 continents


Industry membership


Ethics & Business Integrity

Advance

Sustainable

Health Systems

Champion

Solutions for

Global Health

Challenges

“Global

Health

Progress”Advocate for policies that

enable & recognize the

value of science and

biopharmaceutical

innovation

Build bridges amongst

diverse actors to champion

solutions for improving

public health and patient

outcomes

Promote policies & dialogue

to advance sustainable

financing and health system

reforms, including access &

availability of medicines &

vaccines worldwide

Foster a Sound

Biopharmaceutical

Innovation

Ecosystem

IFPMA strategic priorities

Pharmaceutical Innovation: A long and complex process

IFPMA (2012) The New Frontiers of Biopharmaceutical Innovation. Geneva: International Federation of Pharmaceutical Manufacturers &

Associations, p 9. http://www.ifpma.org/fileadmin/content/Publication/2013/IFPMA_Incremental_Innovation_Feb_2013_Low-Res.pdf


Pharmaceutical industry investment in R&D

European Commission (2015) The 2015 EU Industrial R&D Investment Scoreboard; p50.

http://iri.jrc.ec.europa.eu/scoreboard15.html

9


Innovative Medicines: pushing the

limits of science with a vibrant pipeline

IFPMA (2017), The Pharmaceutical Industry and Global Health: Facts and Figures 2017. PhRMA (2016) Chart Pack

Biopharmaceuticals in Perspective. Washington DC: Pharmaceutical Research and Manufacturers of America, p 22.

IFPMA is advocating for better access to advanced therapies

Growth Projections for Cell and Gene Therapy Market

11

1 Regenerative Medicines Market: Global Opportunity Analysis and Industry Forecast, 2015–2022. Allied Market Research:

Pune,Maharashtra, India: August 2016; www.alliedmarketresearch.com/regenerative-medicines-market.

2 Chartrain NA, Williams CB, Whittington AR. Engineering Tissues with Bioprinting. BioProcess Int. 14(10) 2016: 28–33.

Building Solutions and forming strategic alliances are a key

priority for IFPMA

Drive alliance-building programs with other industries and key opinion leaders

Learn more and

stay connected

www.ifpma.org

introduction to ifpma and their role in global health policy · 2019-05-03 · introduction to...

Documents